Pure red cell aplasia caused by antibody to erythropoietin successfully treated by cyclosporine administration.
Shinohara
Kenji
K
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004921:Erythropoietin / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D004921:Erythropoietin; D016572:Cyclosporine